EMEA-000883-PIP01-10-M05
Key facts
Invented name |
Trecondi
|
Active substance |
Treosulfan
|
Therapeutic area |
|
Decision number |
P/0346/2020
|
PIP number |
EMEA-000883-PIP01-10-M05
|
Pharmaceutical form(s) |
Powder for solution
|
Condition(s) / indication(s) |
Conditioning treatment prior to haematopoietic-progenitor-cell transplantation
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
medac Gesellschaft für klinische Spezialpräparate mbH
Germany |
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-000883-PIP01-10-M05
|
Compliance opinion date |
25/03/2022
|
Compliance outcome |
positive
|